Taouli, Bachir
Hoshida, Yujin
Kakite, Suguru
Chen, Xintong
Tan, Poh Seng
Sun, Xiaochen
Kihira, Shingo
Kojima, Kensuke
Toffanin, Sara
Fiel, M. Isabel
Hirschfield, Hadassa
Wagner, Mathilde
Llovet, Josep M.
Article History
Received: 16 January 2017
Revised: 22 March 2017
Accepted: 4 April 2017
First Online: 24 April 2017
Compliance with ethical standards
:
: The scientific guarantor of this publication is Bachir Taouli
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: This study has received funding from• National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK099558).• NCI grant (1P30CA165979-01)• European Commission Horizon 2020 (HEP-CAR, proposal 667273-2)• the Samuel Waxman Cancer Research Foundation• Grant I + D Program (SAF2013-41027)• the Asociación Española Contra el Cáncer (AECC).• Fondation ARC (SAE2014060 1302).XXX.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: All study subjects have been previously reported in: Chiang DY, Villanueva A, Hoshida Y, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 2008;68(16):6779-88.
: • retrospective• observational• performed at one institution